6LS5
Structure of human liver FBPase complexed with covalent allosteric inhibitor
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SSRF BEAMLINE BL19U1 |
Synchrotron site | SSRF |
Beamline | BL19U1 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2019-01-01 |
Detector | PSI PILATUS 6M |
Wavelength(s) | 1.06 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 67.599, 83.523, 276.929 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 42.842 - 2.031 |
R-factor | 0.1963 |
Rwork | 0.194 |
R-free | 0.23730 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 5zwk |
Data reduction software | XDS |
Data scaling software | XDS |
Phasing software | PHASER |
Refinement software | PHENIX (1.14_3260) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 42.842 | 2.041 |
High resolution limit [Å] | 2.031 | 2.031 |
Number of reflections | 1353784 | 12417 |
<I/σ(I)> | 11.34 | 2.29 |
Completeness [%] | 99.7 | |
Redundancy | 8.4 | |
CC(1/2) | 0.996 | 0.765 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 7.2 | 291 | 0.05 M Tris (pH 6.8), 10% (v/v) polyethylene glycol 8000 |